Expert profiles - HollandBIO · PDF fileExpert profiles This document ... ABN AMBRO ttopstart PNO Consultants ... the merger between Transave Inc. and Insmed (INSM

Expert profiles

This document contains all profiles of the experts present at the Dutch Life Sciences SME Event on

the 4th of June 2015. They are specialized in:

1. Financing & Calls

2. Legal & IP

3. Consultancy Services

Register on the HollandBIO website to schedule a one-on-one meeting with these experts.

https://www.hollandbio.nl/events/dutch-life-sciences-sme-event

1. Financing & Calls

Forbion Capital Partners

Aglaia Ventures

Thuja Capital

BioGeneration Ventures

Innovation Quarter

Mibiton Foundation

RVO

TKI-LSH

ABN AMBRO

ttopstart

PNO Consultants

Drug Discovery Factory / Catalyze

Deloitte

Expert: Geert-Jan Mulder Function: Partner E-mail: [email protected] Telephone number: +31 35 699 3018 Expertise: Financing, Clinical Development strategy, Medical Marketing etc. Interest: Drug Development , Diagnostics, Medical Devices, Therapies, Drug discovery Biodiversity, Food, etc.

Biography: Geert-Jan Mulder MD is an experienced life sciences investor and led multiple deals in both Europe and US, where he was involved in 17 investments in this sector. Based on his background in clinical development he assists various Forbion portfolio companies in building their clinical development strategies. Geert-Jan is General Partner at Forbion Life Sciences, a Netherlands based venture capital firm which was spun out of ABN AMRO Capital in 2006. Dr Mulder is a medical doctor and received his medical degree from the University of Utrecht in the Netherlands. In 2001, he was registered as a Pharmaceutical Physician. Prior to joining ABN AMRO Capital in 2001, he was Clinical Research Manager for The Netherlands for Byk Gulden (now Nycomed), where his department dealt with the design and execution of numerous phase 1, 2 and 3 clinical trials. Prior to joining Byk Gulden he was with Searle (now Pfizer) working in the field of arthritis & pain as a Medical Adviser, being involved in the clinical development as well as local and European advocate development in the pre-launch roll-out for Celebrex (celecoxib). Dr Mulder currently serves on the board of Promedior Inc, Exosome Diagnostics Inc, bluebirdbio (formerly Genetics Pharmaceuticals), Provecica Ltd. and PanGenetics BV. Before going public he represented AAC LS on the board of Acorda Therapeutics where he was part of the Fampridine-SR board panel to evaluate a new clinical endpoint in Multiple Sclerosis, which became the basis for their successful pivotal phase III trial. Geert-Jan's accomplishments include: i) the sale of Pangenetics in 2009 for USD 190 million, as a member of the M&A committee, ii) successful IPO of Acorda Therapeutics in 2006, where he supported the company in various areas, iii) end of 2010 the merger between Transave Inc. and Insmed (INSM - NASDAQ), as a member of the M&A committee. In addition to his position as general partner at Forbion, Geert-Jan provides scientific feedback to a number of portfolio companies and actively works together with management teams in various task forces or advisory committees to add value to their clinical, regulatory programs and corporate

Forbion Capital Partners

strategy. His efforts supported robust development programs, IND filings, a Special Protocol Approval (SPA) by the FDA and Orphan designation for 3 potential treatments in the US as well as EU. Prior to joining the ABN AMRO Capital Life Sciences (AAC LS) team in 2001, he was Clinical Research Manager for The Netherlands for Byk Gulden (now Nycomed), where his department dealt with the design and execution of numerous phase I/IIa, IIb, IIIa and IIIb clinical trials in the fields of Gastroenterology, Respiratory Medicine (asthma and COPD), Intensive Care Medicine and Imaging. He was a Member of the Global Medical Marketing group of the Respiratory Franchise and was involved in the line extension program for Pantozol (pantoprazole). Prior to joining Byk Gulden he was with Searle (now Pfizer) working in the field of Arthritis & Pain as a Medical Adviser, being involved in the clinical development as well as local and European advocate development in the pre-launch roll-out for Celebrex (celecoxib). Geert-Jan received his Medical Degree from the University of Utrecht in the Netherlands. During and after his internships he spent two years as a clinician in Obstetrics and Gynaecology at the University Medical Center of Utrecht (UMC). In 2001, Geert-Jan was awarded his Registration as Pharmaceutical Physician.

Expert: Ernst Geutjes Function: Business analyst E-mail: [email protected] Telephone number: +31 30 229 6092 Expertise: Determination of business strategy of early start-up companies; business case analysis and business plan development; Oncology drug development. Interest: Platform technologies that can be applied toward development of therapeutic compounds in oncology ; oncology diagnostics with clear clinical utility.

Biography: Ernst is a business-orientated scientist with broad scientific training in oncology, infectious diseases and chemistry with a strong interest in valorization of science. Ernst obtained his Msc. In biomedical sciences at the University of Amsterdam and Harvard Medical School and received his PhD in molecular cancer genetics from the Netherlands Cancer Institute (NKI-AvL). He then continued his career as business developer at TNO, where he gained experience in marketing, business consultancy, international business development and venturing. He had a major role in spinning-out technologies from the Earth, Environmental and Life Sciences department. He currently works as business analyst at Aglaia Biomedical Ventures, a venture capital firm with a focus in oncology diagnostics and therapeutics. Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development. At Aglaia, Ernst is responsible for analysis of investment proposals as well scouting for new investment opportunities.

Aglaia Ventures

Expert: Michel Briejer Function: Venture capitalist E-mail: [email protected] Telephone number: +31 30 253 3849, +31 6 2246 2927 Expertise: Investeren in jonge life sciences-ondernemingen, productontwikkeling. Interest: Jonge life sciences ondernemingen (drugs, medical devices, etc.).

Biography: Meer dan 6 jaar actief als VC investeerder. Daarvoor loopbaan bij grote en kleinere farmaceutische en biotech-ondernemingen (Janssen Pharmaceutica, Yamanouchi, Crucell) alsmede consultancy, waarbij brede ervaring is opgedaan met productontwikkeling. Studie farmacie gevolgd door promotie, tevens post-doctorale opleiding Pharmaceutical Medicine afgerond.

Thuja Capital

Expert Edward van Wezel

Function Managing Partner

Email: [email protected]

Tel. nummer +31356993000

Expertise:

Financing, IP, Business Development, Early stage companies, Drug Development, Process Engineering

Interest:

Therapeutics, Drug discovery, Diagnostics, Medical Devices, Food

Biography

Edward has extensive international expertise in small and large pharma and biotech companies He started his industrial career as process engineer for Chiron Inc. where he was involved in setting up manufacturing facilities in Amsterdam for the production of Beta-interferon. He worked for Johnson & Johnson as project manager and was responsible for preclinical and Phase II product development projects in the oncology franchise. In addition he was involved in in-licensing activities for Johnson & Johnson. Since 2000 he gained experience in several small start-up and early stage companies in the Netherlands. He was director business development at Pepscan Systems and managing director of Macrozyme. At Macrozyme Edward was responsible for the complete pre-clinical development of a new oral anti-diabetic compound that under his responsibility was successfully partnered with Genzyme Inc. in 2005. Since 2006 he is managing partner of Biogeneration Ventures and serves on the board of Progentix Orthobiology BV, NovioGendix BV and Arcarios BV, Edward holds a M.Sc in chemistry from the University of Utrecht and a M.Sc in Biochemical Engineering from the University of Delft.

BioGeneration Ventures

Expert: Gerty Holla Function: Investment manager E-mail: [email protected] Telephone number: +31 88 474 7284 Expertise: Seed investments in life sciences startups. Interest: Bedrijven die financiering zoeken.

Biography: Investment manager InnovationQuarter sinds 2014 Consultant at Vectrix/ Nextstage sinds 2014 Investment manager BioPartner Startup Ventures 2000-2013 Stafmedewerker Adviesraad voor Wetenschaps- en Technologiebeleid 1998-2000 Manager Amsterdam Science Park 1997-1998 Investment-manager Zernike Seed Fund 1991-1997

Innovation Quarter

Expert: Kees Recourt Function: Investeringsmanager E-mail: [email protected] Telephone number: +31 6 223 86513 Expertise: Investeringsmanager Life Sciences apparatuur. Programmamanager BioBusiness Masterclass.

Biography: Mibiton maakt het voor jonge Life Sciences bedrijven mogelijk om te investeren in apparatuur en

faciliteiten. Er zijn 3 fondsen beschikbaar. ‘Science’, voor startende bedrijven die nog een sterke

binding met de kennisinstelling hebben (maximale krediet is € 200.000,-). ‘Solo’, voor jonge, snel

groeiende bedrijven die reeds enige omzet genereren of een eerste investeringsronde hebben

afgesloten (maximaal € 350.000,-). ‘Share’, voor het delen van apparatuur en faciliteiten tussen

meerdere partners, waarvan minimaal 1 MKB bedrijf (maximaal € 750.000,-). De kredieten worden

verschaft als hoog-risico rentedragende leningen (looptijd 2-5 jaar). Intakegespreken mogelijk

tijdens SME Event. Zie voor details de website: www.mibiton.nl.

Mibiton Foundation

Expert: Christine de Oliveira Function: Kredietadviseur & coordinator Life Sciences and Health E-mail: [email protected] Telephone number: +31 88 602 5645 Expertise: Ondernemingsfinanciering vanuit de overheid (Seed, Innovatiekrediet, Garantieregelingen met nadruk op Innovatiekrediet = projectfinanciering); Life Sciences sector (biotech- / pharma–MKB). Interest: Financiering van klinische ontwikkelingstrajecten, diagnostische kits, en medical devices. Biography:

Promotieonderzoek vaccinontwikkeling fac. Diergeneeskunde, Utrecht; Scientist OctoPlus, Leiden – microsphere controlled release technologie en

vaccinontwikkeling; Rijksdienst voor Ondernemend Nederland, Ministerie van Economische Zaken: sinds 2006 = de start van de kredietregelingen (Uitdagerskrediet en nu Innovatiekrediet), coördinator Life Sciences aanvragen: van gesprekspartner, c.q. advisering ondernemer over zijn financieringsvraagstukken tot/met beoordeling van het businessplan en projectplan in een aanvraag voor Innovatiekrediet.

RVO

Expert: Laila El Aziz Function: Programmacoördinator TKI LSH E-mail: [email protected] Telephone number: +31 70 344 0672 Expertise: TKI regelingen Biography: Sinds September 2014 ben ik werkzaam bij de Topsector Life Sciences Health als programma coördinator TKI regeling. Ik ben het aanspreekpunt voor vragen over deze regeling en coördineer de uitvoer van de TKI toeslagregeling.

TKI - LSH

Expert: Matthijs van den Heuvel E-mail: [email protected] Expertise: Bank financing

Company information: Address Telephone number Website Markplein 11 +31 20 383 1364 www.abnamro.com

2132 DA Hoofddorp Company introduction: ABN AMRO serves retail, private and commercial banking clients in the Netherlands and across the globe with a comprehensive range of products and services. We also offer national and international advisory services, based on our in-depth financial expertise, extensive knowledge of numerous sectors and an international network. We aim to respond alertly to the ever-changing market and our clients’ ever-changing needs. Today’s clients want a bank that acts in the context of today’s realities and is straightforward with them; a bank that learns from its experiences and whose top priority is to provide the best possible service. M2M-promotion: ABN AMRO offer a completely free advice, for your company.

ABN AMRO

Expert: Jochem Bossenbroek Function: Partner Expertise: Non-dilutive funding & business development in the life sciences & medtech Expert: Jasper Levink Function: Partner Expertise: Non-dilutive funding & business development in the life sciences & medtech

ttopstart

Company information: Address Telephone number Website

PC Staalweg 30 030 737 0779 www.ttopstart.nl 3721 TJ Bilthoven Company introduction: ttopstart is a European science and business consulting company that serves leading

researchers and innovative companies in the fields of life sciences, medical technology and

health. We acquire funding for cutting-edge research and development, co-create corporate

strategies and conduct detailed market assessments.

The services of ttopstart are designed to leverage the potential of innovations in life sciences,

medical technology and health. Collaborating with ttopstart can be highly cost-effective and

result in acceleration of product development and commercialisation.

Particularly strong in:

Raising non-dilutive funding for innovative SMEs

Developing stakeholder-targeted commercialisation strategies

M2M-promotion: HollandBIO members are welcome to approach ttopstart for a cost-free quick scan for non-dilutive funding options. In the quick scan we search for loans, grants and subsidies for each step in your product development.

Expert: Corjan Visser Function: Manager Life Sciences & Health team E-mail: [email protected] Telephone number: +31 6 1314 5536 Expertise: Grants and innovation consultancy

PNO Consultants

Company information: Address Telephone number Website Evert van de Beekstraat 366 +31 20 655 6090 www.pnoconsultants.com 118 ZX Luchthaven Schiphol

Company introduction: PNO is a full-service independent grants and innovation consultancy, providing services

throughout Europe to a wide range of clients from SMEs to multinational companies, non-profit

organizations, technological platforms, multi-stakeholder partnerships, universities and

governments.

PNO arranges financing solutions for organizations that innovate and invest. Together with our

clients we not only develop projects, business plans and financing requests , but also provide

support in stakeholder analyses, dissemination- and exploitation plans and the execution of

these projects. We match your innovation plans to government policies and use both public and

private sources to realize your ambitions.

Because of the fact that our sector specialists (e.g. in Life Sciences & Health) really understand

your business (talk your talk) and also thanks to 30 years of experience, our extensive European

network and our direct involvement in hundreds of project, our success rate is far above market

average.

M2M-promotion: In the M2M-promotion for HollandBIO members, PNO offers a free first consult in which the business plan development- and/or financing opportunities will be investigated. Moreover, all HollandBio members is offered free access to PNO’s partner- & project search web based tool “Innovation Place”.

Expert: Henk Viëtor Function: CEO Expertise: Non-dilutive funding, grants, loans, licensing opportunities

Expert: Kirsten van Benthem

Function: Consultant

Expertise: Non-dilutive funding, grants, loans, licensing opportunities

Drug Discovery Factory


Joop Geesinkweg 167 +31 20 723 4413 www.drugdiscoveryfactory.com 1114 AB Amsterdam-Duivendrecht

Company introduction: Drug Discovery Factory (DDF) is a life science management organization transforming leading academic research into successful business propositions. DDF selects the most attractive research projects at leading University Medical Centers, arranges funding, facilitates the spin-off process, provides project management and administrative/financial support, files patents and commercializes the results. Catalyze (a DDF firm) is specialized in non-dilutive funding (grants, loans and licensing opportunities). We believe these very powerful financing instruments are mandatory for a successful Life Sciences company. The complexity and impact of grants and loans requires careful guidance by a company like Catalyze/DDF.

M2M-promotion: DDF is a company for entrepreneurs by entrepreneurs. In 15 years we started numerous biotech

companies and learned often very expensive but valuable lessons in the Life Sciences business.

Although grants and loans provide an interesting source of alternative funding for Life Sciences

companies, implementing such instruments in your financial plans is difficult and not without

risks. We know how to optimally modulate these instruments in your financial models thereby

maximize the potential and limiting the risks.

Our offer is analyze your situation, find the right alternative funding instruments and modulate

these funding sources in your financial model.

Expert: Helene Geijtenbeek Function: Director Tax E-mail: [email protected] Expertise: Tax, grant & incentives

Expert: Diederik Appelboom Function: Consultant R&D and Government Incentives Expertise: Tax, grants & incentives

Deloitte


Wilhelminakade 1 +31 088 288 2888 www.deloitte.com 3072 AP Rotterdam

Company introduction: Deloitte provides industry-leading audit, consulting, tax, and advisory services to many of the world’s most admired brands, including 70% of the Fortune 500. Deloitte has more than 210,000 professionals in more than 150 countries and territories. Our people work across more than 20 industry sectors with one purpose: to deliver measurable, lasting results. We help reinforce public trust in our capital markets, inspire clients to make their most challenging business decisions with confidence, and help lead the way toward a stronger economy and a healthy society. Deloitte serves 71% of the 2014 Fortune Global 500 Life Sciences & Health Care companies, 10 of the 10 largest global pharma manufacturers, 8 of the 10 largest global biotechnology companies and 10 of the 10 largest global medical equipment manufacturers. Please take a look at our website to read our latest reports on connected health or the 2015 Life Sciences sector outlook.

M2M-promotion: Our local teams give in-country support in order to achieve our client’s strategy objectives.

Deloitte offers proven industry knowledge through an extensive track record and experience in

regional, national and EU grants. Our integrated teams consist of both financial and

technological trained personnel to understand your situation and we offer proprietary

technology solutions to enable a structured approach.

2. Legal & IP

Axon Lawyers

Allen & Overy

Nauta Dutilh

NLO

VO Patents & Trademarks

Loyens & Loeff

Kien Legal

BarentsKrans

Expert: Carine van den Brink Function: Lawyer Expertise: Private equity, patent licensing, pharmaceutical contracts

Axon Lawyers


Piet Heijnkade 088 650 6500 www.axonadvocaten.nl 1019 HC Amsterdam Company introduction: Axon Lawyers is an Amsterdam based law firm with an international orientation. The company's

focus is on the legal and regulatory aspects of the life sciences sector. Axon offer over 30 years of

experience in this sector, gained as attorney at law and in-house counsel.

M2M-promotion: Axon Lawyers offers to HollandBio members a free intake meeting at our office in Amsterdam.

Expert: Frits Gerritzen Function: Counsel Expertise: Intellectual property

Allen & Overy

Company information: Address Telephone number Website Apollolaan 15 +31 20 674 1000 www.allenovery.com 1977 AB Amsterdam +31 6 5152 0203

Company introduction: Allen & Overy offers the full spectrum of legal support in the life sciences sector. We act for

(listed) companies and their investors across the industry, including in the pharmaceuticals,

biotech, veterinary, medtech, diagnostics and healthcare sectors. Our international network

ensures that we have a ready resource of expertise in a number of jurisdictions, including those

in emerging markets, and that we are well positioned to advise on cross-border work. We have

won a reputation for providing far-sighted advice to some of the world’s leading life science

companies.

M2M-promotion: We propose the following promotions to HollandBIO members:

Intellectual property matters: the first billable hour of a new matter will be free of charge. On a

matter by matter basis, we will decide whether the intake meeting in relation to the new matter

or the first billable hour of the new matter will be free of charge. This promotion is solely

applicable for matters coordinated by the Allen & Overy Amsterdam office and work carried out

by the lawyers of the Allen & Overy Amsterdam office.

Expert: Gijs ter Baak Function: Deputy civil law notary Telephone number: +31 20 717 1636 or +31 6 2250 2439 Expertise: Corporate legal and notarial support

Nauta Dutilh

Company information: Address Telephone number Website Strawinskylaan 1999 +31 20 717 1000 www.nautadutilh.com 1077 XV Amsterdam

Company introduction: NautaDutilh is a leading independent, full service law firm in the Netherlands, Belgium and Luxemburg. We are among the largest law firms in Europe, with over 400 lawyers, civil law notaries and tax advisers in offices in Amsterdam, Brussels, London, Luxembourg, New York and Rotterdam. We assist the domestic and international business community with advice and litigation in areas such as corporate law, capital markets, tax, intellectual property, competition, employment, commercial property and insurance.

M2M-promotion: Dedicated team that knows your business NautaDutilh's interdisciplinary Life Sciences Team offers top-class legal expertise and in-depth market knowledge. We advise (inter)national clients in the pharmaceutical, biotechnology and medical devices field ranging from start-up ventures to industry leaders. Behind the scenes, in transactions, before the regulators and in court. Full service built around your life cycles Our services are built around our clients' product and company life cycle: from starting a company, financing rounds and investment arrangements through to acquisition by listed life sciences companies or other exits such as an IPO and high-end regulatory and litigation services, including on product launches and distribution, advertising, clinical trials, generic entry, patent litigation and product liability issues. Proven track record NautaDutilh's Life Sciences Team is recognized as a go-to full-service adviser in the Benelux life sciences industry. Our track record includes clients such as Crucell, Johnson & Johnson, Pfizer/ Wyeth and Shire.

Expert: Bart Swinkels Function: Partner Expertise: Patent applications, patent landscaping, IP strategy

NLO

Company information: Address Telephone number Website Anna van Buerenplein 21A +31 70 331 2500 www.nlo.nl 2595 DA The Hague

Company introduction: NLO is one of the largest and most prominent Intellectual Property consultancies in Europe, boasting a client list that includes multinationals, SMEs, universities, R&D and governmental organizations. We protect and reinforce our clients’ ideas, innovations and trademarks, bearing in mind the markets in which they are involved. This has been the key ingredient of our services for over 125 years and they will continue to be pivotal in the future as well. We offer services over a broad area (patents in all aspects, trademarks, agreements, formalities administration, payment of official fees and renewal fees). With over 60 patent and trademark attorneys we have several dedicated Life Sciences teams and expertise in many other technical domains. M2M-promotion: Patent landscaping provides you with valuable business intelligence, enabling you to find out more about the technological sector in which you operate. Who are your competitors and what patent application strategies do they follow? Which innovation trends can be seen in the market? NLO’s patent landscaping analyses provides insight into how to define your patent strategy. For HollandBIO members NLO offers a basic package patent landscaping for € 1.500,= ex VAT. The NLO basic package patent landscaping includes: Fee for NLO Searcher; Fee for advice by NLO patent attorney; Number of publications per year; Top 20 patent owners (overall, last 5 years); Country overview/ pattern; Keywords analysis; Patent density 1 code (e.g. CPC); and Excel-report with all results.

Expert: Bart van Wezenbeek Function: Senior associate European Patent Attorney Expertise: IP, biotech, plants

VO Patents & Trademarks

Company information: Address Telephone number Website Johan de Wittlaan 7 +31 70 416 6711 www.vo.eu 2517 JR Den Haag

Company introduction: V.O. Patents & Trademarks is one of the larger independent Intellectual Property firms in Europe. We offer services in patent and trademark protection, as well as market and engineering intelligence in terms of IP. We have wide expertise and many years of experience in Chemistry, Electronics, Life Sciences, Mechanics and Physics. More than 60 attorneys support clients worldwide to maximize the value of their intellectual property. Clients range from tech starters and midsized innovators to knowledge centers and multinationals. They include leading national and international companies and institutes. With offices in the Netherlands, Belgium and Germany, we operate in a global network of professionals. Our work is recognized worldwide by the IP industry. V.O. is praised as "a center of excellence" in Intellectual Asset Magazine and received The Netherlands prosecution IP Firm of the Year Award from Managing IP Magazine. M2M-promotion: To help innovative entrepreneurs make the right choices and decisions in terms of intellectual property protection - patents, trademarks, designs -, V.O. has introduced the V.O. service voucher. This voucher is presented to persons who are seriously interested in learning how they can optimally benefit from IP protection. How they can activate their ideas! It stands for two hours of free IP consultancy with a V.O. expert specialized in one’s line of business, without any further obligation. The service voucher is personal and nontransferable, and is valid from three months from the date of issue.

Expert: Stephan Sluiter Function: Attorney-at-law Expertise: Legal

Expert: Michiel Schul Function: Tax lawyer Expertise: Tax

Company information: Address Telephone number Website Blaak 31 +31 10 224 6316 www.loyensloeff.com 3011 GA Rotterdam

Company introduction: Loyens & Loeff employs over 800 attorneys at law, tax advisers and civil law notaries in the Netherlands, Belgium and Luxembourg and various financial centers worldwide. Our associates have extensive experience in all legal and tax areas relevant to biotech companies. Our focus areas include regulatory issues, tax law, environmental law, data protection, tariff regulation, advertising, product liability, customs, financing and corporate law. Among our clients are most major pharmaceutical companies and various promising start-ups.

M2M-promotion: Every quarter Loyens & Loeff offers a free consultation hour for HollandBIO members. Members can freely discuss their legal issues. If you are interested you can subscribe via [email protected] in accordance with the question.

Loyens & Loeff

Expert: Marylin Maas Function: Director Expertise: Healthcare regulations, pharmaceutical law

Kien Legal


K.P. van der Mandelelaan 74 +31 10 480 8550 www.kienlegal.nl 3062 MB Rotterdam

Company introduction: KienLegal is a Dutch legal firm with a strong position in the Dutch health care sector. Our firm is situated in Rotterdam, the Netherlands. Like this city, KienLegal is known for its no-nonsense approach. We offer our clients legal strategy based solutions within the following fields: health law, pharmaceutical law, administrative law, corporate law and competition law. Over the last 15 years we have developed extensive experience on price regulation in health care (rates and performance), health insurance law, access, reimbursement and regulatory health care law, rules of conduct for negotiations between insurers and health care providers, quality regulation, law on research and development privacy, compensation files, issues specific to general, specialized and supra-regional care (policy makers and providers), hospital and general practice.

M2M-promotion: The health care sector is especially known for its rapidly evolving changes. Healthcare administrators and professionals experience continual pressure. KienLegal is a leading law firm and consultant agency within the healthcare and pharmaceutical market. Every service provided by KienLegal is aimed at providing legal strategy based solutions. Such solutions can only be found when having thorough knowledge of the health care market and the specific interests of its participants. KienLegal is respected and known for both features. Our practice focuses on advising and litigation. When possible, we prefer solving problems for our clients outside the court. When needed, we litigate tough, however fair. We assist our clients as team and with commitment.

Expert: Marleen van den Horst Function: Partner IE & technologie E-mail: [email protected] Telephone number: +31 70 376 0621 Expertise: Patent enforcement strategy & litigation

Expert: Jaap Bremer Function: Partner IE & technologie E-mail: [email protected] Telephone number: +31 70 376 0621 Expertise: IP transactions, pharmaceutical trademarks, advertising

Expert: Harry Rek Function: Partner E-mail: [email protected] Telephone number: +31 70 376 0654 Expertise: Private equity, finance

BarentsKrans


Lange Voorhout 3 +31 70 376 0606 www.barentskrans.nl 2514 EA Den Haag

Company introduction: BarentsKrans is an independent Dutch law firm located in The Hague with nearly 70 lawyers. Besides

experts on Intellectual Property & Technology, the firm also includes specialists in the following areas:

Supreme Court Litigation, Corporate Litigation, Financial Litigation, Corporate and M&A, Competition

Law, Labour Law and Real Estate. Our knowledge and experience in the field of Healthcare & Life

Sciences is bundled in a specialist group.

BarentsKrans is a member of HollandBIO at the initiative of the Intellectual Property & Technology group.

The experts in this group regularly advise clients from the pharmaceutical, biotech and medical devices

industry and therefore possess profound knowledge of the sector.

BarentsKrans has been involved in many of the high-profile pharmaceutical patent/SPC and regulatory

cases that have been litigated in The Netherlands over the past years. We are, for instance, involved in the

preparation of patent litigation concerning monoclonal antibodies. In addition, we assist our clients in

pharmaceutical, trademark and advertising matters, such as disputes on comparative advertising.

Apart from litigating, members of our Healthcare & Life Sciences industry group assist clients in e.g.

negotiating and drafting licences, technology transfer and distribution agreements and setting up joint

ventures. The Dutch life sciences industry is among the world's best. To keep ahead of the competition it

is essential that the right alliances are formed. Additionally, short and mid-term capital requirements

remain a constant challenge. BarentsKrans is regularly instructed in life sciences related M&A and Finance

transactions.

M2M-promotion: We offer you free consultation and advice for a maximum of 3 hours. Depending on the further services required, we can discuss alternate fee structures.

3. Consultancy Services

3D-PharmXchange

Kinesis Pharma

Zwiers Regulatory

Xendo

Scalable Life Sciences

Match2Win

Expert: Ronald van der Geest Function: Partner Expertise: Drug development strategy & start-up support

3d-PharmXchange


Maidstone 48A +31 13 534 8272 www.3d-pcx.com 5026 SK Tilburg

Company introduction: 3D-PharmXchange is a world class Dutch consultancy firm specialized in development of

pharmaceuticals, medical devices and diagnostics. We provide advice and support in order to

make expert skills available to small and mid-size pharma on a highly flexible need-based way. In

addition, we reinspire big pharma teams by insertion into their existing operation. Our team of

PhD’s covers expertise in the key areas of non-clinical, clinical, CMC and regulatory affairs.

Furthermore, we provide support in the field of marketing, communications, business

development, out-lisensing and interim management. As we integrate all required expertise, we

are the one-stop-shop to support your development program. Our role varies from temporary

replacement to full development program design (including management positions). Through

our long-standing experience we know how to take your development program seamlessly to the

next level, which enhances an efficient way of working.

M2M-promotion: 3D-PharmXchange celebrates its 5th anniversary with all HollandBIO members! We offer HollandBIO member 5 hours free expert advice on their next consulting project or a one-time free development plan review. Our experts will quickly scan your materials to identify potential hurdles.

Expert: Kees Groen Function: CEO Expertise: Due diligence, drug development and PK/PD

Expert: Kees Bol Function: Senior director drug development Expertise: Early drug development strategy and due diligence/gap analysis

Kinesis Pharma

M2M-promotion: 1. Alliance4U initiative to bridge financial and other business challenges helping drug candidates move forward. 2. Course on Drug Development and Course on Pharmacokinetics and Biometrics. 3. Early Drug Development Support


Lage Mosten 29 +31 76 548 0666 www.kinesis-pharma.com 4822 NK Breda

Company introduction: Kinesis Pharma is a drug development enabling company for the pharmaceutical and biotech

industry and has a leading position and proven track record in fast and effective early drug

development (from candidate selection up to POC in patients, including regulatory affairs and

formulation development). The company understand that resources are limited, especially for

start-ups. Therefore, the company focus on the critical activities that need to be done to bring a

project to a next stage efficiently so that maximal value is obtained upon exit.

Expert: Alex Zwiers Function: CEO Expertise: Regulatory pharmacovigilance support

Zwiers Regulatory


Molenstraat 110 +31 6 1048 9150 www.az-regulatory.com 5342 CC Oss

Company introduction: Zwiers Regulatory Consultancy provides regulatory and pharmacovigilance support for drugs and medical devices throughout the entire product lifecycle. Our services include:

strategic advice: regulatory strategy plan, target product profile, device classification, due dilligence

regulatory and medical writing: dossier elements (Common Technical Document modules, STED, essential requirements, BSER, Clinical Evaluation), reports, product information and instructions for use

health authority interactions: meeting preparations with Health Authorities and Notified bodies, briefing packages, inspection preparation

pharmacovigilance advice and documents: risk analysis and management, reporting Zwiers also provides training and education. The company is located in Pivot Park in Oss,

The Netherlands.

M2M-promotion: Zwiers Regulatory Check: Free of charge! What? A check for any regulatory actions that may apply to your project/product depending on the R&D development stage. Think of: due diligence, regulatory strategy, health authority meetings, starting clinical trials. How? By meeting us in our offices and benefitting from 1 hour of Professional advice with a personal approach.

Expert: Ienke Munninghof Function: Director Regulatory Affairs Expertise: Reg. affairs, CMC, strategic maintenance, pharmacovigilance

Expert: Rene Nanninga

Function: Director Engineering & Technical Support

Expertise: Research / production facility design and realization

Expert: Kirsten Lingbeek Function: Compliance & Validation, R&D Expertise: R&D, QA, project management, clinical trial materials

Xendo


Archimidesweg 17 +31 71 524 4000 www.xendo.com 2333 CM Leiden

Company introduction: Xendo is a leading consultancy and project management organisation in the fields of (bio-)pharmaceutical products, medical devices and healthcare. Around 130 experienced and highly educated professionals provide strategic advice, project management and implementation, interim management, auditing, operational support and training. Our services focus on Regulatory Affairs, Product Development, E-compliance & Data Management, Pharmacovigilance, Engineering, Qualification & Validation and Quality Management & Operational Excellence. For over 25 years we have successfully completed thousands of national and international assignments for start-ups as well as for the largest, established multinational companies and organisations. It is our mission to provide optimal solutions for our life science customers during the full life cycle of their products and health care solutions. We enhance processes related to quality and safety of your product and we strive to shorten the time to market. WE PROVIDE SOLUTIONS FOR LIFE SCIENCES

M2M-promotion: Xendo offers a free intake meeting for HollandBIO members.

Expert: Rob Janssen Function: CEO Expertise: Corporate communications, public affairs and investor relations

Scalable Life Sciences


Palissanderhout 2 +31 79 362 2950 www.scalablels.com 2719 KW Zoetermeer

Company introduction: Scalable Life Sciences is a strategic communications consultancy specializing in life sciences. The company offers consultancy and execution in corporate communications, public affairs, governmental affairs, market access, investor relations and marketing communications. Our expertise, unique experience and extensive network will help you to get your messages across, connect you to the right people and maximize your results. Scalable applies a scalable and effective approach to deliver maximum results for its clients. This effectiveness is based on an optimal reinforcement of your corporate communication and - for example - your investor relations or governmental affairs. The company’s list of current and past clients includes organizations like: Alliance for Advanced Therapies, Amsterdam Molecular Therapeutics, Bavarian Nordic, Biotechnology Industry Organization, Carmat, Celgene, Royal DSM, PwC, SkylineDx, Syngenta, TI Pharma and Vertex.

M2M-promotion: Promotion: The initial interview is always free. HolladBIO members will receive a five percent

discount of their first contract.

Expert: Silvia van Hoof Function: Owner & senior consultant Expertise: Recruitment of qualified personnel for middle and senior management in Healthcare

Match2Win


Allegondahoeve 39 06 53 11 38 73 www.match2win.nl 2131 NB Hoofddorp Company introduction: Match2Win is a partner in finding highly qualified personnel for the Healthcare in the middle and senior management. The company has developed standardized procedures relating to recruitment. Validated selection methods lead to continuous improvement of services. Match2Win has experience in recruiting graduates college graduates and academics to positions in the healthcare industry. The company provides in coorporation a complete portfolio for the healthcare.

M2M-promotion: For HollandBIO members, M2W (Match2Win) offers a discount of 25% of the normal fee in order

to get in touch with our distinguished way of selecting your future personnel.

Documents

Expert profiles - HollandBIO · PDF fileExpert profiles This document ... ABN AMBRO ttopstart PNO Consultants ... the merger between Transave Inc. and Insmed (INSM